129 related articles for article (PubMed ID: 38066647)
1. Reduction in Pappalysin-2 Levels and Lower IGF-I Bioavailability in Female Adolescents With Anorexia Nervosa.
Barrios V; Martín-Rivada Á; Guerra-Cantera S; Campillo-Calatayud A; Camarneiro RA; Graell M; Chowen JA; Argente J
J Clin Endocrinol Metab; 2024 Feb; 109(3):e920-e931. PubMed ID: 38066647
[TBL] [Abstract][Full Text] [Related]
2. Pappalysins and Stanniocalcins and Their Relationship With the Peripheral IGF Axis in Newborns and During Development.
Martín-Rivada Á; Guerra-Cantera S; Campillo-Calatayud A; Andrés-Esteban EM; Sánchez Holgado M; Martos-Moreno GÁ; Pozo J; Güemes M; Soriano-Guillén L; Pellicer A; Oxvig C; Frystyk J; Chowen JA; Barrios V; Argente J
J Clin Endocrinol Metab; 2022 Sep; 107(10):2912-2924. PubMed ID: 35902207
[TBL] [Abstract][Full Text] [Related]
3. Increased IGFBP proteolysis, IGF-I bioavailability and pappalysin levels in children with Prader-Willi syndrome.
Barrios V; Martín-Rivada Á; Martos-Moreno GÁ; Canelles S; Moreno-Macián F; De Mingo-Alemany C; Delvecchio M; Pajno R; Fintini D; Chowen JA; Argente J
J Clin Endocrinol Metab; 2023 Dec; ():. PubMed ID: 38141219
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy associated plasma protein-A2 (PAPP-A2) and stanniocalcin-2 (STC2) but not PAPP-A are associated with circulating total IGF-1 in a human adult population.
Nimptsch K; Aydin EE; Chavarria RFR; Janke J; Poy MN; Oxvig C; Steinbrecher A; Pischon T
Sci Rep; 2024 Jan; 14(1):1770. PubMed ID: 38245583
[TBL] [Abstract][Full Text] [Related]
5. Anthropometric and biochemical correlates of PAPP-A2, free IGF-I, and IGFBP-3 in childhood.
Fujimoto M; Khoury JC; Khoury PR; Kalra B; Kumar A; Sluss P; Oxvig C; Hwa V; Dauber A
Eur J Endocrinol; 2020 Mar; 182(3):363-374. PubMed ID: 31961798
[TBL] [Abstract][Full Text] [Related]
6. Placental proteases PAPP-A and PAPP-A2, the binding proteins they cleave (IGFBP-4 and -5), and IGF-I and IGF-II: Levels in umbilical cord blood and associations with birth weight and length.
DiPrisco B; Kumar A; Kalra B; Savjani GV; Michael Z; Farr O; Papathanasiou AE; Christou H; Mantzoros C
Metabolism; 2019 Nov; 100():153959. PubMed ID: 31401027
[TBL] [Abstract][Full Text] [Related]
7. Decreased serum levels of acid-labile subunit in patients with anorexia nervosa.
Fukuda I; Hotta M; Hizuka N; Takano K; Ishikawa Y; Asakawa-Yasumoto K; Tagami E; Demura H
J Clin Endocrinol Metab; 1999 Jun; 84(6):2034-6. PubMed ID: 10372706
[TBL] [Abstract][Full Text] [Related]
8. Novel Modulators of the Growth Hormone - Insulin-Like Growth Factor Axis: Pregnancy-Associated Plasma Protein-A2 and Stanniocalcin-2.
Fujimoto M; Hwa V; Dauber A
J Clin Res Pediatr Endocrinol; 2017 Dec; 9(Suppl 2):1-8. PubMed ID: 29280739
[TBL] [Abstract][Full Text] [Related]
9. IGFBP-4 and PAPP-A in normal physiology and disease.
Hjortebjerg R
Growth Horm IGF Res; 2018 Aug; 41():7-22. PubMed ID: 29864720
[TBL] [Abstract][Full Text] [Related]
10. The Stanniocalcin-PAPP-A-IGFBP-IGF Axis.
Oxvig C; Conover CA
J Clin Endocrinol Metab; 2023 Jun; 108(7):1624-1633. PubMed ID: 36718521
[TBL] [Abstract][Full Text] [Related]
11. The relationship between bone turnover and body weight, serum insulin-like growth factor (IGF) I, and serum IGF-binding protein levels in patients with anorexia nervosa.
Hotta M; Fukuda I; Sato K; Hizuka N; Shibasaki T; Takano K
J Clin Endocrinol Metab; 2000 Jan; 85(1):200-6. PubMed ID: 10634387
[TBL] [Abstract][Full Text] [Related]
12. IGFBP-4 and -5 are expressed in first-trimester villi and differentially regulate the migration of HTR-8/SVneo cells.
Crosley EJ; Dunk CE; Beristain AG; Christians JK
Reprod Biol Endocrinol; 2014 Dec; 12():123. PubMed ID: 25475528
[TBL] [Abstract][Full Text] [Related]
13. The IGF system in patients with inflammatory bowel disease treated with prednisolone or infliximab: potential role of the stanniocalcin-2 / PAPP-A / IGFBP-4 axis.
Hjortebjerg R; Thomsen KL; Agnholt J; Frystyk J
BMC Gastroenterol; 2019 Jun; 19(1):83. PubMed ID: 31159802
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy-associated plasma protein-A is involved in insulin-like growth factor binding protein-2 (IGFBP-2) proteolytic degradation in bovine and porcine preovulatory follicles: identification of cleavage site and characterization of IGFBP-2 degradation.
Monget P; Mazerbourg S; Delpuech T; Maurel MC; Manière S; Zapf J; Lalmanach G; Oxvig C; Overgaard MT
Biol Reprod; 2003 Jan; 68(1):77-86. PubMed ID: 12493698
[TBL] [Abstract][Full Text] [Related]
15. Clinical and biochemical determinants of bone metabolism and bone mass in adolescent female patients with anorexia nervosa.
Audí L; Vargas DM; Gussinyé M; Yeste D; Martí G; Carrascosa A
Pediatr Res; 2002 Apr; 51(4):497-504. PubMed ID: 11919336
[TBL] [Abstract][Full Text] [Related]
16. Metabolic improvement after gastric bypass correlates with changes in IGF-regulatory proteins stanniocalcin-2 and IGFBP-4.
Hjortebjerg R; Bojsen-Møller KN; Søeby M; Oxvig C; Madsbad S; Frystyk J
Metabolism; 2021 Nov; 124():154886. PubMed ID: 34506805
[TBL] [Abstract][Full Text] [Related]
17. Involvement of pregnancy-associated plasma protein-A2 in insulin-like growth factor (IGF) binding protein-5 proteolysis during pregnancy: a potential mechanism for increasing IGF bioavailability.
Yan X; Baxter RC; Firth SM
J Clin Endocrinol Metab; 2010 Mar; 95(3):1412-20. PubMed ID: 20103653
[TBL] [Abstract][Full Text] [Related]
18. Effects of recombinant human insulin-like growth factor (IGF)-I and estrogen administration on IGF-I, IGF binding protein (IGFBP)-2, and IGFBP-3 in anorexia nervosa: a randomized-controlled study.
Grinspoon S; Miller K; Herzog D; Clemmons D; Klibanski A
J Clin Endocrinol Metab; 2003 Mar; 88(3):1142-9. PubMed ID: 12629097
[TBL] [Abstract][Full Text] [Related]
19. Low serum levels of free and total insulin-like growth factor I (IGF-I) in patients with anorexia nervosa are not associated with increased IGF-binding protein-3 proteolysis.
Støving RK; Flyvbjerg A; Frystyk J; Fisker S; Hangaard J; Hansen-Nord M; Hagen C
J Clin Endocrinol Metab; 1999 Apr; 84(4):1346-50. PubMed ID: 10199777
[TBL] [Abstract][Full Text] [Related]
20. Use of the ligand immunofunctional assay for human insulin-like growth factor ((IGF) binding protein-3 (IGFBP-3) to analyze IGFBP-3 proteolysis and igf-i bioavailability in healthy adults, GH-deficient and acromegalic patients, and diabetics.
Lassarre C; Duron F; Binoux M
J Clin Endocrinol Metab; 2001 May; 86(5):1942-52. PubMed ID: 11344189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
